Vaccines MDPI

Vaccines (Impact Factor: 7.8 (2022); 5-Year Impact Factor: 7.4 (2022); ISSN 2076-393X) has a history of publishing peer-reviewed state-of-the-art research that advances the knowledge of immunology in human disease protection. Immunotherapeutics, prophylactic vaccines, immunomodulators, adjuvants, and the global differences in regulatory affairs are some of the highlights of the research published that have shaped global health. Our aim is to encourage scientists to publish their experimental and theoretical results in an open-access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced and computed data or files regarding the full details of the experimental procedure can be deposited as supplementary material. Subject Areas: - immunology mechanisms - animal models for immunologic diseases - viral immunology - immunopathogenesis - vaccine development and efficacy evaluation - immune responses to vaccines - vaccine technology - vaccine vectors, adjuvants and immunomodulators - prophylactic vaccines, therapeutic vaccines, AIDS vaccines, gene vaccines, vaccines in bioterrorism - regulatory affairs, commercial utilization, policy, safety, epidemiology